Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-25 @ 2:32 AM
NCT ID:
NCT00165334
Eligibility Criteria:
Inclusion Criteria:
* 70 years of age or greater
* Stage IV or IIIB Non-small cell lung cancer
* Must at least be able to walk and capable of taking care of yourself although unable to carry out work activities
* 3 or more weeks since completing prior radiotherapy
* 3 or more weeks since prior major surgery
* Blood tests that show your kidneys, liver and bone marrow to be working adequately
* Life expectancy of 8 weeks or more
Exclusion Criteria:
* Prior anticancer therapy within the past 3 years, including chemotherapy
* Other currently active cancer
* Uncontrolled Central Nervous System (CNS) problems
* Pre-existing disease or abnormality of the nervous system
* Hepatitis or Known HIV
* Active uncontrolled infection
* Incomplete healing from previous major surgery
* Significant history of uncontrolled cardiac disease such as high blood pressure, recent heart attack (within past 6 months), congestive heart failure, etc.
* Prior therapy which targets the ErbB pathway
* Prior severe infusion reaction to an antibody
* Chemotherapy or other investigational agent not indicated in the study protocol occuring at the same time as this study treatment
* A medical condition that could make it unsafe for you to participate in this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
70 Years
Study:
NCT00165334
Study Brief:
Protocol Section:
NCT00165334